The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Ryvu Therapeutics
Leadership - Ryvu Therapeutics
Stock and Other Ownership Interests - Merus; Ryvu Therapeutics
Honoraria - Ryvu Therapeutics
Research Funding - Ryvu Therapeutics
Travel, Accommodations, Expenses - Ryvu Therapeutics
Updated results from DIAMOND-01 (CLI24-001) trial: A phase I/II study of SEL24/MEN1703, a first-in-class dual PIM/FLT3 kinase inhibitor, in acute myeloid leukemia.
 
Scott R. Solomon
No Relationships to Disclose
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Roche; Shire
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
Aziz Nazha
Stock and Other Ownership Interests - Amazon
Honoraria - DCI Pharmaceuticals
Consulting or Advisory Role - Karyopharm Therapeutics; Tolero Pharmaceuticals
Speakers' Bureau - Incyte; Novartis
Research Funding - Jazz Pharmaceuticals
 
Stephen Anthony Strickland
Consulting or Advisory Role - Abbvie; Archer; Genentech; Incyte; Kura Oncology; Novartis; Pfizer; Syros Pharmaceuticals
Research Funding - Sunesis Pharmaceuticals (Inst)
 
Giovanni Martinelli
Consulting or Advisory Role - Abbvie; Celgene; Daichii Sankyo; Incyte; Jazz Pharmaceuticals; Pfizer; Roche
Speakers' Bureau - Jazz Pharmaceuticals; Menarini; Novartis
Research Funding - Daichii Sankyo; Pfizer
Travel, Accommodations, Expenses - Abbvie; daichii sankyo; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Pfizer
 
Armando Santoro
Consulting or Advisory Role - ARQULE; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Bayer; BMS; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Roland B. Walter
Stock and Other Ownership Interests - Amphivena Therapeutics
Consulting or Advisory Role - Agios; Amgen; argenx; Astellas Pharma; BiolineRx; BiVictriX; Daiichi Sankyo; Emergent Biosolutions; Janssen; Kite, a Gilead company; Kronos; Macrogenics; Newlink Genetics; Pfizer; Race Oncology
Research Funding - ADC Therapeutics (Inst); Agios (Inst); Amgen (Inst); Aptevo Therapeutics; Arog (Inst); BiolineRx (Inst); Celgene; Immunogen (Inst); Janssen Research & Development (Inst); Jazz Pharmaceuticals (Inst); Macrogenics (Inst); Pfizer; Seagen (Inst); Selvita (Inst); Stemline Therapeutics (Inst)
 
Rachel J. Cook
No Relationships to Disclose
 
Maria Calbacho
No Relationships to Disclose
 
Susana Vives
No Relationships to Disclose
 
Salman Fazal
Honoraria - Agios; Amgen; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Incyte; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Novartis; Sanofi; Stemline Therapeutics; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Incyte; Karyopharm Therapeutics; Novartis; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Incyte; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Novartis; Sanofi; Stemline Therapeutics; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Incyte; Janssen; Karyopharm Therapeutics; Novartis; Sanofi; Stemline Therapeutics; Takeda
 
Krzysztof Brzózka
Employment - Ryvu Therapeutics
Leadership - Ryvu Therapeutics
Stock and Other Ownership Interests - Nodthera; Ryvu Therapeutics
Honoraria - Ryvu Therapeutics
 
Setareh Shamsili
No Relationships to Disclose
 
Simone Baldini
Employment - Menarini
 
Dirk Laurent
Employment - Berlin-Chemie
Stock and Other Ownership Interests - Bayer
 
Andrea Ugo Enrico Pellacani
Employment - Menarini
Stock and Other Ownership Interests - Amgen; Amgen (I)
 
Farhad Ravandi
Honoraria - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Celgene; Jazz Pharmaceuticals; Novartis; Orsenix; Pfizer; Takeda
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Celgene; Certara Inc; Jazz Pharmaceuticals; Orsenix; Syros Pharmaceuticals; Taiho Oncology; Taiho Oncology
Research Funding - Amgen; Bristol-Myers Squibb; Cellerant; Macrogenics; Selvita; Xencor